Company: MYSEW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004290
Chunk: 168

Company: Myseum, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 168
---
 that we have effective internal controls over
financial reporting in accordance with Section 404 of Sarbanes-Oxley. Moreover, effective internal controls are necessary for us to produce
reliable financial reports and are important to helping prevent financial fraud. If we cannot provide reliable financial reports or prevent
fraud, our business and operating results could be harmed, investors could lose confidence in our reported financial information, and
the trading price of our common stock could drop significantly.

Comprehensive tax reform bills could adversely
affect our business and financial condition.

The U.S. government recently enacted comprehensive
federal income tax legislation that includes significant changes to the taxation of business entities. These changes include, among others,
a permanent reduction to the corporate income tax rate. Notwithstanding the reduction in the corporate income tax rate, the overall impact
of this tax reform is uncertain, and our business and financial condition could be adversely affected. This Annual Report on Form 10-K
does not discuss any such tax legislation or the manner in which it might affect purchasers of our common stock. We urge our shareholders
to consult with their legal and tax advisors with respect to any such legislation and the potential tax consequences of investing in
our common stock.

22

We could issue “blank check”
preferred stock without stockholder approval with the effect of diluting interests of then-current stockholders and impairing their voting
rights, and provisions in our charter documents and under Nevada law could discourage a takeover that stockholders may consider favorable.

Our Amended and Restated Articles of Incorporation
provides for the authorization to issue up to 20,000,000 shares of “blank check” preferred stock with designations, rights
and preferences as may be determined from time to time by our board of directors. Our board of directors is empowered, without stockholder
approval, to issue one or more series of preferred stock with dividend, liquidation, conversion, voting or other rights which could dilute
the interest of, or impair the voting power of, our common stockholders. The issuance of a series of preferred stock could be used as
a method of discouraging, delaying or preventing a change in control. For example, it would be possible for our board of directors to
issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of our
company. In addition, advanced notice is required prior to stockholder proposals, which might further delay a change of control.

Our ability to have our securities traded